World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
93
Citations
33171
World Ranking
10853
National Ranking
5587

Mitchell S. Cairo publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Mitchell S. Cairo sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 852 publications — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Mitchell S. Cairo D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Mitchell S. Cairo sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 93 D-Index — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Mitchell S. Cairo is affiliated with New York Medical College in the United States and has an extensive research record primarily in the field of medicine. Their work focuses on specialized subfields including oncology, hematology, genetics, immunology, and pathology and forensic medicine.

The scientist's research covers several main topics. These include:

  • CAR-T cell therapy research
  • Lymphoma diagnosis and treatment
  • Immune cell function and interaction
  • Hematopoietic stem cell transplantation
  • Acute lymphoblastic leukemia research
  • Acute myeloid leukemia research
  • Hemoglobinopathies and related disorders

Major publication venues in which Mitchell S. Cairo has contributed extensively include:

  • Blood
  • Transplantation and Cellular Therapy
  • Biology of Blood and Marrow Transplantation
  • Regular and Young Investigator Award Abstracts
  • Leukemia Research

Frequent collaborators in their research community include:

  • Janet Ayello
  • Dean A. Lee
  • Yaya Chu
  • Lauren Harrison
  • Allyson Flower

Selected recent publications presenting the scientist's work are as follows:

  • Modified diagnostic criteria, grading classification and newly elucidated pathophysiology of hepatic SOS/VOD after haematopoietic cell transplantation, 2020, British Journal of Haematology
  • Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia, 2021, Blood Advances
  • Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide, 2020, Biology of Blood and Marrow Transplantation
  • Pediatric versus adult high grade glioma: Immunotherapeutic and genomic considerations, 2022, Frontiers in Immunology
  • Combinatorial immunotherapy of N-803 (IL-15 superagonist) and dinutuximab with ex vivo expanded natural killer cells significantly enhances in vitro cytotoxicity against GD2+ pediatric solid tumors and in vivo survival of xenografted immunodeficient NSG mice, 2021, Journal for ImmunoTherapy of Cancer

Best Publications

  • Guidelines for the Management of Pediatric and Adult Tumor Lysis Syndrome: An Evidence-Based Review

    Bertrand Coiffier;Arnold Altman;Ching-Hon Pui;Anas Younes

  • A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome

    Corey S. Cutler;Stephanie J. Lee;Peter Greenberg;H. Joachim Deeg

  • Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease

    John E. Wagner;Joseph Rosenthal;Joseph Rosenthal;Robert Sweetman;Robert Sweetman;Xiao Ou Shu;Xiao Ou Shu

  • Risk factors for acute GVHD and survival after hematopoietic cell transplantation.

    Madan Jagasia;Mukta Arora;Mary E D Flowers;Nelson J. Chao

  • A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis

    Stanton C. Goldman;John S. Holcenberg;Jerry Z. Finklestein;Raymond Hutchinson

  • Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus.

    Mitchell S. Cairo;Bertrand Coiffier;Alfred Reiter;Anas Younes

  • Placental and/or umbilical cord blood: an alternative source of hematopoietic stem cells for transplantation

    Mitchell S. Cairo;John E. Wagner

  • Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients

    Catherine Patte;Anne Auperin;Mary Gerrard;Jean Michon

  • Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure

    Michel Duval;John P. Klein;Wensheng He;Jean Yves Cahn

  • Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents

    Mitchell S. Cairo;Mary Gerrard;Richard Sposto;Anne Auperin

  • Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling

    Jon J. Van Rood;Fausto R. Loberiza;Mei Jie Zhang;Machteld Oudshoorn

  • Generation of keratinocytes from normal and recessive dystrophic epidermolysis bullosa-induced pluripotent stem cells

    Munenari Itoh;Maija Ht Kiuru;Mitchell S. Cairo;Angela M. Christiano

  • Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States

    Jeffrey I. Cohen;Elaine S. Jaffe;Janet K. Dale;Stefania Pittaluga

  • Impaired Neutrophil Function in Patients With AIDS or AIDS-Related Complex: A Comprehensive Evaluation

    Mark Ellis;Sudhir Gupta;Stanley Galant;Said Hakim

  • Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS.

    Selina M. Luger;Olle Ringdén;Mei-Jie Zhang;Waleska S. Pérez

  • Analysis of Risk Factors for Outcomes After Unrelated Cord Blood Transplantation in Adults With Lymphoid Malignancies: A Study by the Eurocord-Netcord and Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

    Celso A. Rodrigues;Guillermo Sanz;Claudio G. Brunstein;Jaime Sanz

  • Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant.

    M. Eapen;S. A. Giralt;M. M. Horowitz;J. P. Klein

  • Non-Hodgkin Lymphoma in Children and Adolescents: Progress Through Effective Collaboration, Current Knowledge, and Challenges Ahead

    Véronique Minard-Colin;Laurence Brugières;Alfred Reiter;Mitchell S. Cairo

  • Hematopoietic Cell Transplantation for Systemic Mature T-Cell Non-Hodgkin Lymphoma

    Sonali M. Smith;Linda J. Burns;Koen W. van Besien;Jennifer LeRademacher

  • Origins and unconventional behavior of neutrophils in developing zebrafish. Commentary

    Mitchell S. Cairo;Dorothée Le Guyader;Michael J. Redd;Emma Colucci-Guyon

Frequent Co-Authors

Megan S. Lim
Megan S. Lim University of Pennsylvania
Hillard M. Lazarus
Hillard M. Lazarus Case Western Reserve University
Joseph E. Schwartz
Joseph E. Schwartz Stony Brook University
Daniel J. Weisdorf
Daniel J. Weisdorf University of Minnesota
Mei-Jie Zhang
Mei-Jie Zhang Medical College of Wisconsin
Bipin N. Savani
Bipin N. Savani Vanderbilt University Medical Center
Michael A. Pulsipher
Michael A. Pulsipher University of Utah
Harry C. Schouten
Harry C. Schouten Maastricht University
Corey Cutler
Corey Cutler Harvard University
Warren G. Sanger
Warren G. Sanger University of Nebraska Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine doesn't always mean following the traditional MD route. Many students explore flexible, affordable online degrees to enter or advance in the healthcare field. A popular option is enrolling in one of the cheapest online nurse practitioner programs, which prepare graduates for advanced clinical roles and greater autonomy in patient care.

For those starting out, there are affordable nursing programs online that offer accredited pathways toward becoming a registered nurse (RN). RNs looking to upgrade their qualifications might consider what is the cheapest rn to bsn program online to enhance their skills and career opportunities.

Ambitious nurses seeking leadership or academic roles could pursue an online nursing doctorate, providing expertise for research, teaching, or executive positions. By choosing affordable, high-quality online programs, students can balance their studies with work and family life while progressing on a meaningful career pathway in healthcare.

Best Scientists Citing Mitchell S. Cairo

Trending Scientists

Recently Published Articles